Skip to content

Harrow, Inc.

American pharmaceutical company

HROW Nasdaq SEC CIK 1360214

Follow Harrow Weekly email: filings, results, news

News

6 stories filed under Harrow, grouped into ongoing threads

Q2

Thread · 3 stories

Harrow (HROW) Q2 2026 Earnings Call Transcript

Earnings 38 d ago

Harrow: The Q2 Turnaround Is Enough For A Cautious Buy

Markets 42 d ago

Harrow Q2 Earnings Call Highlights

Earnings 44 d ago 2 sources

More coverage

Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target

Markets 35 d ago

Harrow reports positive study results for eye anesthesia gel

Markets 35 d ago

Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?

Markets 42 d ago also on VTRS

Profile

Headquarters: NASHVILLE, TN, United States
Founded: 1998
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: harrow.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

News · 6 stories clustered from the RSS aggregator